INSERM (INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCH MEDICALE)
Patent Applications and Registrations
Patent applications and USPTO patent grants for INSERM (INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCH MEDICALE).The latest application filed is for "use of antagonists of th17 cytokines for the treatment of bronchial remodeling in patients suffering from allergic asthma".
- INSERM (INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCH MEDICALE) - Paris FR
- INSERM (INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCH MEDICALE - Paris FR
| Patent | Date |
|---|---|
| Use Of Antagonists Of Th17 Cytokines For The Treatment Of Bronchial Remodeling In Patients Suffering From Allergic Asthma App 20220033486 - TSICOPOULOS; Anne ; et al. | 2022-02-03 |
| Antibodies Having Specificity For The Orf2i Protein Of Hepatitis E Virus And Uses Thereof For Diagnostic Purposes App 20210269510 - COCQUEREL-DEPROY; Laurence ; et al. | 2021-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 